Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cannabist Co Holdings (CBSTF) EBIT (2021 - 2025)

Cannabist Co Holdings' EBIT history spans 5 years, with the latest figure at -$12.0 million for Q3 2025.

  • For Q3 2025, EBIT fell 113.83% year-over-year to -$12.0 million; the TTM value through Sep 2025 reached -$49.9 million, up 41.96%, while the annual FY2024 figure was -$22.3 million, 78.84% up from the prior year.
  • EBIT for Q3 2025 was -$12.0 million at Cannabist Co Holdings, up from -$15.8 million in the prior quarter.
  • Across five years, EBIT topped out at $8.0 million in Q2 2024 and bottomed at -$360.8 million in Q4 2022.
  • The 5-year median for EBIT is -$13.9 million (2024), against an average of -$36.3 million.
  • The largest annual shift saw EBIT plummeted 4849.74% in 2022 before it surged 16238.78% in 2024.
  • A 5-year view of EBIT shows it stood at -$84.8 million in 2021, then crashed by 325.2% to -$360.8 million in 2022, then skyrocketed by 78.46% to -$77.7 million in 2023, then skyrocketed by 82.09% to -$13.9 million in 2024, then rose by 13.55% to -$12.0 million in 2025.
  • Per Business Quant, the three most recent readings for CBSTF's EBIT are -$12.0 million (Q3 2025), -$15.8 million (Q2 2025), and -$8.2 million (Q1 2025).